DossierENTITY

CDSCO

Coverage of CDSCO in the Nexus archive.

Earliest in view: Jul 21 · 06:09 UTCMost recent: Jul 21 · 06:09 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJul 21 · 06:09 UTCTHE HINDU NATIONAL
CDSCO clears recombinant live attenuated dengue vaccine for ages 4 to 60 years
CDSCO has approved a recombinant live attenuated dengue vaccine for individuals aged 4 to 60 years. The Union Health Ministry stated the approval followed a comprehensive evaluation of the vaccine's quality, safety, and efficacy.